n-acetylgalactosaminuronic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N-acetylgalactosaminuronic acid: epitope common to the O-polysaccharides of Pseudomonas aeruginosa serotype A & H [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID Source	ID
PubMed CID	134107
SCHEMBL ID	7156151
MeSH ID	M0180822

Synonyms (11)

Synonym
galnaca
2-(acetylamino)-2-deoxy-l-galacturonic acid
2-n-acetyl-2-deoxygalacturonic acid
2-n-acetyl-2-deoxy-l-galacturonic acid
2-nadga
n-acetylgalactosaminuronic acid
82838-35-5
l-galacturonic acid, 2-(acetylamino)-2-deoxy-
(2r,3s,4s,5s)-5-acetamido-2,3,4-trihydroxy-6-oxohexanoic acid
SCHEMBL7156151
2-acetamido-2-deoxy-l-galacturonic acid

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

Timeframe	Studies, This Drug (%)	All Drugs %
pre-1990	0 (0.00)	18.7374
1990's	4 (40.00)	18.2507
2000's	2 (20.00)	29.6817
2010's	3 (30.00)	24.3611
2020's	1 (10.00)	2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.27

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

Metric	This Compound (vs All)
Research Demand Index	12.27 (24.57)
Research Supply Index	2.40 (2.92)
Research Growth Index	4.66 (4.65)
Search Engine Demand Index	0.00 (26.88)
Search Engine Supply Index	0.00 (0.95)

This Compound (12.27)

All Compounds (24.57)

Study Types

Publication Type	This drug (%)	All Drugs (%)
Trials	0 (0.00%)	5.53%
Reviews	0 (0.00%)	6.00%
Case Studies	0 (0.00%)	4.05%
Observational	0 (0.00%)	0.25%
Other	10 (100.00%)	84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Substance	Relationship Strength	Studies	Classes	Roles
uridine diphosphate n-acetylglucosamine Uridine Diphosphate N-Acetylglucosamine: Serves as the biological precursor of insect chitin, of muramic acid in bacterial cell walls, and of sialic acids in mammalian glycoproteins.	2.08	1
galactosamine 2-amino-2-deoxy-D-galactopyranose : The pyranose form of D-galactosamine.. D-galactosamine : The D-stereoisomer of galactosamine.	2.08	1	D-galactosamine; primary amino compound	toxin
acetylgalactosamine Acetylgalactosamine: The N-acetyl derivative of galactosamine.	1.97	1	N-acetyl-D-hexosamine; N-acetylgalactosamine	Escherichia coli metabolite; human metabolite; mouse metabolite
glucosamine D-glucosamine : An amino sugar whose structure comprises D-glucose having an amino substituent at position 2.. 2-amino-2-deoxy-D-glucopyranose : A D-glucosamine whose structure comprises D-glucopyranose having an amino substituent at position 2.	1.97	1	D-glucosamine	Escherichia coli metabolite; geroprotector; mouse metabolite
udp-n-acetylglucosaminuronic acid UDP-N-acetylglucosaminuronic acid: found in Micrococcus luteus	2.02	1
lipid a Lipid A: Lipid A is the biologically active component of lipopolysaccharides. It shows strong endotoxic activity and exhibits immunogenic properties.. lipid A : The glycolipid moiety of bacterial lipopolysaccharide (R can be either hydrogen or a fatty acyl group).	2.13	1	dodecanoate ester; lipid A; tetradecanoate ester	Escherichia coli metabolite
leptin Leptin: A 16-kDa peptide hormone secreted from WHITE ADIPOCYTES. Leptin serves as a feedback signal from fat cells to the CENTRAL NERVOUS SYSTEM in regulation of food intake, energy balance, and fat storage.	2.02	1

Condition	Relationship Strength	Studies
Acinetobacter Infections Infections with bacteria of the genus ACINETOBACTER.	2.25	1
Diabetes Mellitus, Adult-Onset [description not available]	2.02	1
Hyperglycemia, Postprandial Abnormally high BLOOD GLUCOSE level after a meal.	2.02	1
Insulin Sensitivity [description not available]	2.02	1
Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.	2.02	1
Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.	2.02	1
Hyperglycemia Abnormally high BLOOD GLUCOSE level.	2.02	1
Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS.	2.02	1
Neuroblastoma A common neoplasm of early childhood arising from neural crest cells in the sympathetic nervous system, and characterized by diverse clinical behavior, ranging from spontaneous remission to rapid metastatic progression and death. This tumor is the most common intraabdominal malignancy of childhood, but it may also arise from thorax, neck, or rarely occur in the central nervous system. Histologic features include uniform round cells with hyperchromatic nuclei arranged in nests and separated by fibrovascular septa. Neuroblastomas may be associated with the opsoclonus-myoclonus syndrome. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2099-2101; Curr Opin Oncol 1998 Jan;10(1):43-51)	2.04	1
Infections, Pseudomonas [description not available]	1.97	1
Pseudomonas Infections Infections with bacteria of the genus PSEUDOMONAS.	1.97	1

chemdatabank.com